May 7, 2026
Illexcor Therapeutics
Illexcor Therapeutics focuses on discovering and developing new oral treatments for sickle cell disease.
- Round
- Venture - Series Unknown
- Amount raised
- $13M
- Lead investor
- Zynext Ventures
- Industry
- Biotechnology
- Headquarters
- Richmond, United States
- Employees
- 1-10
- Website
- www.illexcor.com
- View profile →
Source: Crunchbase snapshot 2026-05-15